Sclerotherapy for hydroceles.

Department of Urology, Medical University of Southern Africa, Pretoria.
The Journal of Urology (Impact Factor: 3.7). 06/1990; 143(5):940-3.
Source: PubMed

ABSTRACT Sclerotherapy with 3% sodium tetradecyl sulfate and 3.5% rolitetracycline on an outpatient basis was applied to 55 hydroceles. The over-all cure rate was 96% with an average followup of 13 months. Of the patients 64% were cured after only 1 sclerosant instillation. A post-sclerotherapy operation was necessary in 4% of the patients. Pain of a significant degree occurred after sclerotherapy in only 29% of the patients. Sclerotherapy appears to be an effective, economical and safe form of outpatient therapy for hydroceles.

0 0
1 Bookmark
  • [show abstract] [hide abstract]
    ABSTRACT: Is aspiration and sclerosing of hydrocele testis (HT) an effective treatment? Men with symptomatic HT were included in this first prospective double-blind randomized study with aethoxysclerol and placebo. Patients were randomized to either active treatment or placebo at first treatment. Using various doses of Aetoxysklerol dependent on HT size (<100 ml, 100 to 200ml and> 200 ml), the patients were treated with 1 ml, 3 ml or 4 ml Aethoxy-sklerol after aspiration. Patients with recurrence at the 5-week follow-up all received active treatment. A total of 77 patients were included in the study. In Group A (active), there were 36 patients, median age 63 years (34-92) and in B 41 patients' median age 59 years (26-82). The median follow-up time was 72 months. A significant difference between the two groups was observed after both the first and the second treatment. Recurrence after the first treatment was seen in 16 (44%) patients from group A and in 32 (78%) patients in group B (p <0.05); recurrence after retreatment with active drug in both groups was seen in 4 (25%) patients in group A and in 14 (44%) in the former placebo group (p <0.05). The overall success rate of treatment in the active group was 89%. There was no difference between the two groups in terms of volume of fluid aspirated, symptoms or complications. This long-term efficacy randomized study with placebo showed that Aethoxysklerol is effective for treatment of HT with low recurrence rate.
    The Journal of urology 11/2013; · 4.02 Impact Factor
  • [show abstract] [hide abstract]
    ABSTRACT: Spermatoceles are commonly treated with open surgical ablation. With the increasing shift towards minimally invasive surgery and heightened awareness, both patient and surgeon accept and prefer the less intrusive approach. Treatment of spermatoceles translates into the use of aspiration and sclerotherapy rather than open excision. We report on our prospective study of percutaneous aspiration and sclerotherapy with sodium tetradecyl sulfate for treatment of spermatoceles to determine safety, efficacy and cost-effectiveness. Patients with symptomatic cystic scrotal lesions were prospectively enrolled in an aspiration and sclerotherapy protocol between October 1998 and June 2000. All patients underwent aspiration followed by sclerotherapy with a sodium tetradecyl sulfate solution. Followup included clinical assessment and scrotal ultrasonography at 12 weeks and on a needed basis thereafter. A total of 28 patients with 34 spermatoceles were enrolled in the protocol. Mean patient age was 61.0 years and mean spermatocele volume was 89.3 ml. Complete followup was available for 31 of 34 (91%) spermatoceles, and the mean duration of followup was 24.6 weeks. Results were cure in 29% success in 36%, partial success in 19% and failure in 16% of cases. Patient satisfaction was 85% and there were no complications. The total cost of each procedure was only $104 (Canadian), and none took more than 10 minutes. Percutaneous aspiration and sclerotherapy with sodium tetradecyl sulfate is a minimally invasive, simple, safe, inexpensive and reasonably efficacious treatment option for spermatoceles. Initial failures can be salvaged with second treatment.
    The Journal of Urology 08/2001; 166(1):137-9. · 3.70 Impact Factor
  • [show abstract] [hide abstract]
    ABSTRACT: PURPOSE: To demonstrate that hydrocele aspiration and sclerotherapy (AS) with doxycycline is an effective and safe non-surgical treatment option for hydrocele correction. METHODS AND MATERIALS: The medical records of patients who underwent AS were analyzed in a retrospective cohort study for success rates and improvement in scrotal size and discomfort after a single AS treatment. Patients who reported reduced scrotal size, improved physical symptoms, and satisfaction with the procedure were considered as having success with AS. RESULTS: Twenty nine patients (mean age 52.8) presenting with 32 non-septated hydroceles underwent AS with doxycycline between 2005 and 2012. Twenty seven hydroceles (84%) were successfully treated with a single AS procedure. The overall mean follow up time was 20.8 months. Three patients reported moderate pain which resolved in 2-3 days. For those who failed AS; 1 successfully resolved with a second AS, 3 were unsuccessful with a second AS and underwent hydrocelectomy, and 1 desired immediate surgical correction. CONCLUSION: AS was successful in correcting 84% of simple non-septated hydroceles with a single treatment. This result is an increase from previously reported success rates involving a single AS with tetracycline (75%). The success rate of a single AS is similar to reported success rates involving hydrocelectomy while avoiding the hospital expense and many of the complications. We conclude that AS is a reasonable, non-surgical, and under-utilized treatment option for non-septated simple hydroceles.
    The Journal of urology 11/2012; · 4.02 Impact Factor